Lung cancer
Conditions
Interventions
control group:Nil
experimental group:Continuous rhomboid intercostal nerve block
Sponsors
Affiliated Hospital of Jiaxing University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: From November 2020 to December 2022, 60 patients underwent unilateral thoracoscopic lobectomy in the first hospital of Jiaxing City, 60 patients, aged 18-80 years, ASA I - III.
Exclusion criteria
Exclusion criteria: 1. Patients in shock or coma; 2. Patients with abnormal heart, lung, liver, kidney and coagulation function; 3. For those patients with infection in the block area, severe nerve injury occurred in the block side; 4. Patients with chronic pain, history of taking analgesics, psychotics, radiotherapy and chemotherapy, and contraindications to non steroidal anti-inflammatory drugs; 5. Patients allergic to local anesthetics such as lidocaine, ropivacaine and general anesthetics; 6. Patients and their families refused anesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Turkish version of 40-item quality of recovery questionnaire (QoR-40);Opioid use;Postoperative pain NRS pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative remedial drug dosage;Incidence of nausea and vomiting;Incidence of adverse reactions; | — |
Countries
china
Contacts
Public ContactWei Deng
Affiliated Hospital of Jiaxing University
Outcome results
None listed